Sept. 14, 2019 at 8 p.m., advocates gathered in Indianapolis, Ind. across the street from the headquarters of Eli Lilly and Co., one of the three largest insulin manufacturers in the world. The nonpartisan vigil they came to attend was organized to mourn the loss of and honor the lives of people who died from insulin rationing.
According to JAMA Internal Medicine one of every four patients with type 1 diabetes has had to ration insulin because of its cost. The percentage is even higher for young adults. It was not always this expensive. Since the 1990’s, BMJ Global Health cites, the cost of insulin has increased over 1,200%, yet the cost of production for one vial of analog insulin is between $3.69 and $6.16.